Panelists to explore new and emerging advances in precision chemoprevention aacrmeetingnews.org/news/panelists…

Looking forward to engaging discussions

Wednesday morning at #AACR24 : Panelists will explore new and emerging advances in precision chemoprevention. Read a preview in AACR Annual Meeting News: bit.ly/3VTisOp Adetunji Toriola

Breast cancer incidence rates among women aged 20-49 is increasing, driven by increases in ER+ tumors. Prevention efforts in young women need to adopt a targeted approach to address racial disparities in incidence rates. ja.ma/4b97yJF

Honored to see our article on the lipidome of mammographic breast density in premenopausal women: rdcu.be/dvYFf featured as one NCI Epidemiology and Genomics Research Program 2023 Research Highlights WashU Public Health Sciences Siteman Cancer Center WashU Surgery.
See epi.grants.cancer.gov/research-highl…

First pictures from the #ColoCare investigator meeting in #Heidelberg - helping patients with #colorectalcancer ⁦Jennifer Ose⁩ ⁦Dr. Biljana Gigić⁩ ⁦Sheetal Hardikar⁩ ⁦Adetunji Toriola⁩ ⁦Victoria Damerell, PhD⁩ ⁦⁦Universitätsklinikum Heidelberg⁩ ⁦Huntsman Cancer Institute⁩

Fascinating work by Kayla Getz describing the lipidome of mammographic breast density. Congratulations on your Women in Cancer Research Scholar Award!

Congratulations to NCI Prevention & Early Detection grantee Dr. Adetunji Toriola of @WUSTLpubhealth for receiving an AACR Outstanding Investigator Award for the important topic of breast cancer prevention in premenopausal women. His presentation at SABCS was excellent.

For the record: Dr. Fauci has done nothing wrong, except serve our nation. In the meantime, Mr. Musk should know that 200,000 Americans needlessly lost their lives from Covid due to this kind of antiscience rhetoric and disinformation. Elon, I’m asking you to take down this Tweet

Abetunji Toriola, MD, PhD of WUSM Department of Medicine shares his conclusions during his AACR Outstanding Investigation presentation on breast cancer prevention in premenopausal women. #sabcs22 OncoAlert

Congratulations to Adetunji Toriola on receiving the AACR Outstanding Investigator Award for Breast Cancer Research by The Breast Cancer Research Foundation at #SABCS2022 for his important work on breast cancer prevention in premenopausal women. 🙌🏾 🇳🇬 WashU Public Health Sciences Washington U. Med

Toriola honored by oncology group medicine.wustl.edu/news/toriola-h… via @wustlmed

Hear what Charles Perou, PhD and Adetunji Toriola, MD have to talk about when they deliver their AACR lectures next week at #SABCS22 . You can also read about it on our blog. sabcs.org/2021-SABCS-sup… UNC Lineberger Washington U. Med

Award Recipients Announced for the 2022 San Antonio Breast Cancer Symposium | AACR | News Releases aacr.org/about-the-aacr…

Adetunji Toriola, MD, PhD, MPH, & Bettina Drake, PhD, MPH, helped host an educational event with Siteman Cancer Center's Program for the Elimination of Cancer Disparities. They offered community members info on breast, colon, & prostate cancer as well as exercises & survivorship.⁠

Dean Perlmutter gave a shout out to the Danforth Physician Scholars in his State of the School address. What a fantastic crew! Albert H. Kim Adetunji Toriola newberrylab

Winship #GrandRounds Webinar - November 9
Adetunji Toriola, MD, PhD, MPH (Adetunji Toriola) | Siteman Cancer Center
'Cancer Prevention: Moving from Discovery to Clinical Translation'
➡️ fal.cn/3tr7O

Heartiest congratulations to Dr. Adetunji Toriola!
“Dr. Toriola is part of a bustling community of physician-scientists who are excelling & poised to advance their fields in innovative and profound ways,” said Dr. Wayne Yokoyama, Associate Dean WU Division of Physician-Scientists
medicine.wustl.edu/news/toriola-n…